Pfizer buys cancer treatment innovator Array BioPharma for $11 billion

Anthony Noto
Pfizer buys cancer treatment innovator Array BioPharma for $11 billion

The New York-based drug giant has been taking over rivals who have developed drugs and gene therapies.